Vir Biotechnology, Inc. (VIR)
NASDAQ·Healthcare·Biotechnology
$9.20
+3.26%
Mkt Cap $1.49B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (19 analysts)
$21.71
Range $18.00 – $30.00
Implied Upside
+136.1%
Consensus $21.71 vs current $9.20
NASDAQ·Healthcare·Biotechnology
$9.20
+3.26%
Mkt Cap $1.49B
Buy
8
Hold
0
Sell
0
Price Target (19 analysts)
$21.71
Range $18.00 – $30.00
+136.1%
Consensus $21.71 vs current $9.20